F8 and inflammatory bowel disease: In the CHEST guidelines, Update 2 provides a stronger statement and “recommends offering extended-phase anticoagulation” for VTE that is “unprovoked or provoked by persistent risk factor.”21Coremans et al recently published algorithms for anticoagulant management of VTE in IBD and gave a weak recommendation for indefinite duration of anticoagulation in case of acute VTE while in remission and a strong recommendation for indefinite treatment in case of recurrent VTE.22These algorithms do not discuss elevated FVIII as a risk factor.